The two-day Congress will provide an interactive and intimate discussion and networking format led by key industry speakers with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies and concepts surrounding orphan drugs and rare diseases.

Over 7,000 different types of rare diseases and disorders exist, with more being discovered each day, and large pharmaceutical and biotech companies are structuring to participate and leverage the growing orphan market. “Orphan drug sales will make up 19% of the total share of prescription drug sales by 2020, totaling 6 billion. And they'll grow at an annual rate of nearly 11% per year through the end of the decade, compared with about 4% for drugs treating larger populations.” (EvaluatePharma’s Orphan Drug Report 2014)

Orphan Drugs & Rare Diseases Global Congress 2015 Europe provides a unique platform for business knowledge sharing and convergence of top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organisations, orphan drugs developers as well as regional and local manufacturers to discuss the driving macroeconomic factors, policies and issues that will steer the development of orphan drugs globally.

Industry Facts
 There are approximately 7,000 different types of rare diseases and disorders, with more being discovered each day
 Approximately 50% of the people affected by rare diseases are children
 30% of children with rare disease will not live to see their 5th birthday
 Rare diseases are responsible for 35% of deaths in the first year of life
 Approximately 50% of rare diseases do not have a disease specific foundation supporting or researching their rare disease

Who Will You Meet
Presidents, Heads/Chiefs, Directors, VPs and Managers of:
 Commercialisation
 Regulatory Affairs
 Market Access
 Sales & Marketing
 Research & Development

More details

Find an actor

4à6 de BioAlps - Tornos15.03.2018

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

UNIBE - Des cultures cellulaires en 3D contre les résistances des cancers

Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn